Comparison of standard versus adjusted dose of enoxaparin for venous thromboembolism prophylaxis in patients with obesity and cancer.

Saved in:
Bibliographic Details
Title: Comparison of standard versus adjusted dose of enoxaparin for venous thromboembolism prophylaxis in patients with obesity and cancer.
Authors: Angerman C; University of California, Davis Health, Sacramento, CA, USA., Ahn J; University of California, San Francisco Health, San Francisco, CA, USA., Gee-Rodriguez K; University of California, San Diego Health, San Diego, CA, USA., Conkey B; University of California, Los Angeles Health, Los Angeles, CA, USA., Tran C; University of California, Irvine Health, Irvine, CA, USA., Nguyen L; University of California, San Francisco School of Pharmacy, San Francisco, CA, USA., Guglielmo J; University of California, Davis Health, Sacramento, CA, USA., Roberts AJ; University of California, Davis Health, Sacramento, CA, USA., Lo M; University of California, San Francisco Health, San Francisco, CA, USA., Lee A; University of California, San Francisco Health, San Francisco, CA, USA., Saunders I; University of California, San Diego Health, San Diego, CA, USA., Willeford A; University of California, San Diego Health, San Diego, CA, USA., Lee D; University of California, Los Angeles Health, Los Angeles, CA, USA., Kim K; University of California, Los Angeles Health, Los Angeles, CA, USA., Cadiz C; University of California, Irvine Health, Irvine, CA, USA.; University of California, Irvine School of Pharmacy & Pharmaceutical Sciences, Irvine, CA, USA., Griffin SP; University of California, Irvine Health, Irvine, CA, USA.; University of California, Irvine School of Pharmacy & Pharmaceutical Sciences, Irvine, CA, USA., Pon T; University of California, Davis Health, Sacramento, CA, USA.; University of California, San Francisco School of Pharmacy, San Francisco, CA, USA.
Source: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2025 May 21, pp. 10781552251345413. Date of Electronic Publication: 2025 May 21.
Publication Type: Journal Article
Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1477-092X
DOI:10.1177/10781552251345413